- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Multiple Sclerosis, Endurance in Korea, Republic of
Total 593 results
-
MinYoung Kim, M.D.CompletedCerebral Palsy | Parkinson's Disease | Brain Injury | Amyotrophic Lateral SclerosisKorea, Republic of
-
National University Hospital, SingaporeCelgene; International Myeloma FoundationUnknownRelapse Multiple MyelomaSingapore, Hong Kong, Japan, Korea, Republic of, Taiwan
-
Corestem, Inc.CompletedMultiple System AtrophyKorea, Republic of
-
Samsung Medical CenterCompletedMarfan SyndromeKorea, Republic of
-
Asan Medical CenterKorea Research Institute of Bioscience & BiotechnologyCompletedLymphoma | Myelodysplastic Syndromes | Leukemia | Chronic Myeloproliferative Disorders | Brain and Central Nervous System Tumors | Unspecified Adult Solid Tumor, Protocol Specific | Multiple Myeloma and Plasma Cell Neoplasm | Lymphoproliferative Disorder | Myelodysplastic/Myeloproliferative NeoplasmsKorea, Republic of
-
Corestemchemon, Inc.Active, not recruitingMultiple System AtrophyKorea, Republic of
-
Yonsei UniversityCompletedMultiple System AtrophyKorea, Republic of
-
Cooperative Study Group A for HematologyCompletedLymphoma | Multiple Myeloma | Chronic Lymphocytic LeukemiaKorea, Republic of
-
Hoffmann-La RocheActive, not recruitingMultiple SclerosisUnited States, Italy, Poland
-
Genzyme, a Sanofi CompanyTerminatedRelapsing-remitting Multiple SclerosisSweden, Poland, Russian Federation, United States, Canada
-
Seoul National University HospitalRecruitingMultiple System AtrophyKorea, Republic of
-
Asan Medical CenterRecruitingPolycystic Kidney Diseases | Kidney Transplant; Complications | Aneurysm, BrainKorea, Republic of
-
Novartis PharmaceuticalsCompletedRelapsing Multiple ScelrosisUnited States, Austria, Belgium, Croatia, Germany, Taiwan, Canada, Czechia, Spain, Argentina, Australia, Peru, South Africa, United Kingdom, Bulgaria, Latvia, Lithuania, Russian Federation, India, Portugal, Italy, Turkey, Finland, France and more
-
Novartis PharmaceuticalsTerminatedRelapsing Remitting Multiple Sclerosis (RRMS)Germany, Spain, Australia, Israel, Switzerland, Italy, Austria, Greece, Hungary, Czech Republic, Finland
-
Seoul National University HospitalUnknownCystic Fibrosis | Bronchiectasis Idiopathic | Primary Ciliary DyskinesiaKorea, Republic of
-
LG Life SciencesCompletedPrader-Willi SyndromeKorea, Republic of
-
MitoImmune TherapeuticsActive, not recruitingLymphoma | Multiple Myeloma | Oral Mucositis | Hematologic CancerKorea, Republic of
-
VA Office of Research and DevelopmentActive, not recruitingMultiple SclerosisUnited States, Canada
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
Merck KGaA, Darmstadt, GermanyMerck spol.s.r.o., Czech RepublicCompletedMultiple Sclerosis, Relapsing-RemittingCzech Republic
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
CinnagenCompletedMultiple Sclerosis | Relapsing-RemittingIran, Islamic Republic of
-
Yonsei UniversityCompleted
-
SanofiRecruitingMultiple SclerosisKorea, Republic of, United States, China, Turkey, Canada, Australia, Puerto Rico, United Kingdom, Japan
-
Chonnam National University HospitalUnknownMultiple MyelomaKorea, Republic of
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisCzech Republic, Poland, Russian Federation, United Kingdom, Hungary, Ukraine, Germany, India
-
BiogenAbbVieTerminatedMultiple Sclerosis | Relapsing-Remitting Multiple SclerosisUnited States, Denmark, Italy, United Kingdom, Czechia, Canada, Hungary, Spain, Australia, Israel, Georgia, Serbia, Russian Federation, Ukraine, India, Poland, Brazil, France, Argentina, Germany, Greece, Ireland, Mexico, Moldova, Republic... and more
-
Synthon BVCompletedMultiple SclerosisUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Croatia, Czech Republic, Estonia, Georgia, Germany, Italy, Mexico, Moldova, Republic of, Poland, Romania, Russian Federation, Serbia, South Africa, Ukraine, United Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States, France, Germany, Spain, Belgium, Czechia, Switzerland, United Kingdom, Austria, New Zealand, Australia, South Africa, Ukraine, Italy, Slovakia, Greece, Poland, Israel, Netherlands, Bulgaria, Serbia, India, Romania, Estonia and more
-
Immunic AGActive, not recruitingMultiple SclerosisUnited States, Germany, Netherlands, Bulgaria, Serbia, Canada, Czechia, Moldova, Republic of, North Macedonia, Poland, Romania, Ukraine
-
SanofiCompletedMultiple Sclerosis Healthy SubjectsUnited Kingdom
-
BiogenCompletedRelapsing-Remitting Multiple SclerosisUnited States
-
Teva Branded Pharmaceutical Products R&D, Inc.CompletedMultiple SclerosisUnited States, Austria, Belarus, Belgium, Bosnia and Herzegovina, Bulgaria, Canada, Croatia, Czechia, Estonia, France, Georgia, Germany, Greece, Hungary, Israel, Italy, Korea, Republic of, Latvia, Moldova, Republic of, Montenegro, North Macedonia and more
-
Yonsei UniversityCompleted
-
BiogenTerminatedRelapsing-Remitting Multiple SclerosisFinland, Germany, Spain, Belgium, Italy, Canada, France, New Zealand, Israel, Hungary, Greece, Australia, Netherlands, United Kingdom, Denmark, Ireland, Sweden, Poland, Czech Republic, Switzerland, Turkey
-
Alzahra Hospital, IranWithdrawnAmyotrophic Lateral SclerosisIran, Islamic Republic of
-
George Washington UniversityCompletedMultiple Sclerosis, Relapsing-RemittingUnited States
-
Tehran University of Medical SciencesCompletedAmyotrophic Lateral SclerosisIran, Islamic Republic of
-
Cooperative Study Group A for HematologyCompleted
-
Isfahan University of Medical SciencesUnknownNeuromuscular DiseasesIran, Islamic Republic of
-
BiogenAbbVieCompletedRelapsing-Remitting Multiple SclerosisSweden, United States, Brazil, Czech Republic, Italy, Russian Federation, Spain, United Kingdom, Germany, Ukraine, Denmark, Finland, Romania, Canada, France, Hungary, Israel, Switzerland, Serbia, India, Mexico, Poland, Georgia, Ireland, Argentin... and more
-
National University Hospital, SingaporeJanssen, LP; International Myeloma FoundationUnknownRelapse and / or Refractory MyelomaSingapore, Hong Kong, Taiwan, Korea, Republic of
-
Yonsei UniversityRecruitingKidney Cancer | Synchronous Neoplasm | Clear Cell Renal Cell Carcinoma MetastaticKorea, Republic of
-
Hoffmann-La RochePPDRecruitingRelapsing-Remitting Multiple SclerosisUnited States, Belgium, Canada, Spain, India, Italy, Mexico, Portugal, Argentina, Austria, Brazil, United Kingdom, Germany, Netherlands, Serbia, Australia, Bulgaria, France, Greece, Hungary, Poland, Ukraine, Estonia, Denmark, Croatia, Latvia and more
-
BiogenTerminatedMultiple Sclerosis, Secondary ProgressiveUnited States, Poland, Belgium, Slovakia, Czech Republic, Netherlands
-
NovartisCompletedMultiple SclerosisUnited States, Korea, Republic of, Portugal, Canada, Hungary, Spain, Germany, United Kingdom, Australia, Argentina, Austria, Belgium, Brazil, Egypt, France, Greece, Italy, Switzerland
-
EMD Serono Research & Development Institute, Inc.Terminated
-
Mapi Pharma Ltd.CompletedMultiple Sclerosis, Relapsing-RemittingUnited States, Belarus, Bosnia and Herzegovina, Bulgaria, Estonia, Georgia, Israel, Moldova, Republic of, Russian Federation, Ukraine
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedMultiple Sclerosis (MS)United States, Lebanon, Spain, Sweden, Poland, Italy, Estonia, Australia, Austria, Belgium, Bulgaria, Canada, Croatia, Czechia, Finland, France, Georgia, Germany, Korea, Republic of, Lithuania, Norway, Portugal, Romania, Russian Federation and more